Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel for Schistosomiasis in Pregnancy
NCT00486863Phase 2
Key facts
- Status
- Completed
- Start
- Aug 2007
- Primary completion
- Nov 2012
- Countries
- 1
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Drugs
- praziquantel
- Conditions
- schistosomiasis
01
Overview
Phase 2, randomised, double-blind trial of praziquantel in schistosomiasis, sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Mean Newborn Birth Weight. Started Aug 2007; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Endpoints
Primary
Mean Newborn Birth Weight
Beyond the preview
Go deeper on NCT00486863.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486863.